021-51111890
购物车（）
sales@molnova.cn
AG-13958
CAS No. 319460-94-1
AG-13958 ( AG-013958 )
产品货号. M20778 CAS No. 319460-94-1
AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor ?for the treatment of age-related macular degeneration.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1458 | 有现货 |
|
| 5MG | ￥2827 | 有现货 |
|
| 10MG | ￥4228 | 有现货 |
|
| 25MG | ￥6861 | 有现货 |
|
| 50MG | ￥9477 | 有现货 |
|
| 100MG | ￥12798 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称AG-13958
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor ?for the treatment of age-related macular degeneration.
-
产品描述AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor ?for the treatment of age-related macular degeneration.
-
同义词AG-013958
-
通路Angiogenesis
-
靶点VEGFR
-
受体VEGFR
-
研究领域——
-
适应症——
化学信息
-
CAS Number319460-94-1
-
分子量467.5
-
分子式C26H22FN7O
-
纯度>98% (HPLC)
-
溶解度DMSO:5 mg/mL (10.70 mM)
-
SMILESCc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1
-
化学全称N-[2-Fluoro-5-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-13-dimethyl-1H-pyrazole-5-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Barakat M R Kaiser P . VEGF inhibitors for the treatment of neovascular age-related macular degeneration[J]. Expert Opinion on Investigational Drugs 2009 18(5):637-646.
产品手册
关联产品
-
Lenvatinib mesylate
Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities.
-
SU14813 maleate
A broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.
-
Asimadoline hydrochl...
Asimadoline HCl is a κ-opioid receptor agonist potentially for the treatment of pruritus. Asimadoline has also been shown to be used in the treatment of irritable bowel syndrome.
